Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

NCT00268723 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Exercise-induced Bronchospasm

Interventions

DRUG: Levalbuterol tartrate HFA MDI
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.